Conference Coverage

VIDEO: Investigating the role of plasmalogens in Alzheimer’s disease


 

AT AAIC 2015

References

WASHINGTON – Could a ubiquitous lipid – manufactured in the liver – be one of the root causes of Alzheimer’s disease? Plasmalogens are important in maintaining cell membrane permeability and effective neurotransmission. They also appear to influence the production of toxic forms of amyloid-beta by affecting the activity of alpha-secretase. What are they, and how strong could their influence in Alzheimer’s be? Dayan Goodenowe, Ph.D., explains at the Alzheimer’s Association International Conference 2015.

Dr. Goodenowe is the founder and CEO of Phenomenome Discoveries, which holds patents on measuring plasmalogen levels and is developing a plasmalogen therapeutic.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Recommended Reading

Cortical volume linked to IQ changes in schizophrenia
MDedge Neurology
Autopsy Study Reveals Underlying AD Pathology
MDedge Neurology
Severity of Alzheimer Disease Differs by APOE Alleles
MDedge Neurology
Physical Fitness and Brain Health
MDedge Neurology
Is Diabetes a Cause of Dementia?
MDedge Neurology
Alberto Ramos, MD
MDedge Neurology
Herpes Simplex Virus 1 and Alzheimer Disease
MDedge Neurology
Mixed pathologies are very common in black Alzheimer’s patients
MDedge Neurology
AAIC: Sedentary early adulthood may mean worse cognitive functioning later
MDedge Neurology
VIDEO: Dementia risk doubled in type 1 diabetes patients
MDedge Neurology